Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

200720062004

2009 Archives

Dec 9, 2009

Philadelphia, PA – December 10, 2009 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its...

More
Nov 23, 2009

Philadelphia, PA – November 23, 2009 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that President and Chief Executive Officer Arthur Bedrosian will ring the opening bell at...

More
Nov 20, 2009

Philadelphia, PA – November 20, 2009 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that its Board of Directors has approved a reauthorization of the stock repurchase...

More
Nov 9, 2009

Fiscal 2010 First-Quarter Highlights: Net sales up 23% to $31.4 million from $25.6 million in the fiscal 2009 first quarter Gross profit grew to $11.5 million compared with $9.0 million in the...

More
Nov 4, 2009

Philadelphia, PA – November 4, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2010...

More
Oct 14, 2009

Philadelphia, PA – October 14, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of Keith R. Ruck as vice...

More
Oct 2, 2009

Philadelphia, PA – October 2, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that it has filed a $150 million universal shelf...

More
Sep 9, 2009

Full-Year Fiscal 2009 Highlights: Net sales up 64% to $119.0 million from $72.4 million in fiscal 2008 Gross profit increased to $45.2 million from $16.3 million in prior year Net income was $6.5...

More
Sep 8, 2009

Philadelphia, PA – September 8, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of Stephen J. Kovary as vice...

More
Jul 16, 2009

Philadelphia, PA – July 16, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that William Farber has resumed the role as...

More
Jun 22, 2009

Philadelphia, PA – June 22, 2009 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company’s shares have been added to the...

More
Jun 9, 2009

Philadelphia, PA – June 9, 2009 – Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of Terence D. Vollrath as executive vice...

More
Apr 2, 2009

Philadelphia, PA – April 2, 2009 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, said today that it is prepared to supply the U.S. market with an...

More
Apr 1, 2009

Philadelphia, PA – April 1, 2009 – Lannett Company, Inc. (NYSE Amex: LCI) today said that it will continue to manufacture and market its Morphine Sulphate products, while it works with...

More
Mar 26, 2009
Company Names Keith Ruck Interim CFO

Philadelphia, PA – March 26, 2009 – Lannett Company, Inc. (NYSE Amex: LCI) today announced that Brian Kearns has resigned as chief financial officer effective March 23, 2009. The...

More
Feb 12, 2009

Lannet (LCI) utilizes Capital Returns, Inc. and incurs the cost of processing and destruction of products returned to Capital Returns. LCI wil not assume responsibility for charges incurred by...

More
 

print email rss
Lannett Investor Relations
Lannett Company Products